T1–T2 tumors, showed higher comparable expression levels in early-stage tumors (mean =551) compared with advanced tumors (mean =5.27), although this difference did not reach statistical significance (P=0.44).
← all excerpts
Divergent roles of PRR11 and HEPACAM in pleural mesothelioma: PRR11 as a prognostic biomarker and HEPACAM as a stage-associated gene with paradoxical expression.
1
0.4400
0.4400